More Than 2% of Circulating Tumor Plasma Cells Defines Plasma Cell Leukemia–Like Multiple Myeloma

Primary plasma cell leukemia (PCL) is the most aggressive monoclonal gammopathy. It was formerly characterized by ≥ 20% circulating plasma cells (CTCs) until 2021, when this threshold was decreased to ≥ 5%. We hypothesized that primary PCL is not a separate clinical entity, but rather that it repres...

Descripción completa

Detalles Bibliográficos
Autores principales: Jelinek, Tomas, Bezdekova, Renata, Zihala, David, Sevcikova, Tereza, Anilkumar Sithara, Anjana, Pospisilova, Lenka, Sevcikova, Sabina, Polackova, Petra, Stork, Martin, Knechtova, Zdenka, Venglar, Ondrej, Kapustova, Veronika, Popkova, Tereza, Muronova, Ludmila, Chyra, Zuzana, Hrdinka, Matous, Simicek, Michal, Garcés, Juan-Jose, Puig, Noemi, Cedena, Maria-Teresa, Jurczyszyn, Artur, Castillo, Jorge J., Penka, Miroslav, Radocha, Jakub, Mateos, Maria Victoria, San-Miguel, Jesús F., Paiva, Bruno, Pour, Ludek, Rihova, Lucie, Hajek, Roman
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2023
Materias:
ORIGINAL REPORTS
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9995102/
https://www.ncbi.nlm.nih.gov/pubmed/36315921
http://dx.doi.org/10.1200/JCO.22.01226

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9995102/
https://www.ncbi.nlm.nih.gov/pubmed/36315921
http://dx.doi.org/10.1200/JCO.22.01226

Ejemplares similares